Capital Fund Management (CFM)
NVCR icon

Capital Fund Management (CFM)’s NovoCure NVCR Stock Holding History

Capital Fund Management (CFM)’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.14M Buy
207,282
+67,753
+49% +$1.03M 0.01% 1164
2026
Q1 		$1.52M Buy
139,529
+68,243
+96% +$852K 0.01% 1502
2025
Q4 		$922K Buy
71,286
+26,514
+59% +$340K ﹤0.01% 2051
2025
Q3 		$578K Buy
+44,772
New +$598K ﹤0.01% 2268
2024
Q4 		– Sell
-27,860
Closed -$590K – 2187
2024
Q3 		$435K Sell
27,860
-72,829
-72% -$1.32M ﹤0.01% 1870
2024
Q2 		$1.72M Buy
100,689
+29,720
+42% +$523K 0.01% 1442
2024
Q1 		$1.11M Buy
70,969
+17,058
+32% +$251K ﹤0.01% 1676
2023
Q4 		$805K Sell
53,911
-61,470
-53% -$823K ﹤0.01% 1887
2023
Q3 		$1.86M Buy
+115,381
New +$3.33M 0.01% 1392
2023
Q2 		– Sell
-14,175
Closed -$852K – 1832
2023
Q1 		$852K Buy
+14,175
New +$1.13M ﹤0.01% 1316
2021
Q1 		– Sell
-24,796
Closed -$4.29M – 1514
2020
Q4 		$4.29M Buy
+24,796
New +$3.39M 0.04% 519
2020
Q2 		– Sell
-24,201
Closed -$1.63M – 1396
2020
Q1 		$1.63M Buy
24,201
+7,270
+43% +$575K 0.03% 587
2019
Q4 		$1.43M Buy
+16,931
New +$1.37M 0.01% 967

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Capital Fund Management (CFM)'s NVCR Position: Q2 2026 in Review

Capital Fund Management (CFM) increased its NovoCure (NVCR) stake by 49% in Q2 2026, buying an estimated $1.03M and bringing the position to 207,282 shares worth $3.14M. The position accounts for 0.01% of the portfolio, ranked #1164.

Capital Fund Management (CFM) first reported a position in NVCR in Q4 2019 and has held it in 13 quarters since. The position peaked at $4.29M in Q4 2020. 218 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • Capital Fund Management (CFM) held 207,282 shares of NovoCure worth $3.14M as of Q2 2026.
  • Capital Fund Management (CFM) bought 67,753 NovoCure shares in Q2 2026, an estimated $1.03M.
  • NovoCure made up 0.01% of Capital Fund Management (CFM)'s portfolio in Q2 2026, its #1164 holding.
  • Capital Fund Management (CFM) first reported a position in NovoCure in Q4 2019 and has held it in 13 quarters since.
  • Capital Fund Management (CFM)'s NovoCure position peaked at $4.29M in Q4 2020.
  • 218 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q2 2026, filed 13 Aug 2026.